个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML.

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE ◇ 自然指数

作者：
Liu Chang[1] * ; Zou Waiyi[2] ; Nie Danian[3] ; Li Shuyi[1] ; Duan Chen[1] ; Zhou Min[1] ; Lai Peilong[4] ; Yang Shengyong[5] ; Ji Sen[5] ; Li Yangqiu[6] ; Mei Mei[7] ; Bao Shilai[7] ; Jin Yanli[8] ; Pan Jingxuan[9] ;
机构： [1]Jinan University Institute of Tumor Pharmacology, College of Pharmacy, Jinan University, Guangzhou 510632, China. [2]Department of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China. [3]Department of Hematology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China. [4]Department of Hematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China. [5]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China. [6]Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou 510632, China. [7]State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China. [8]Jinan University Institute of Tumor Pharmacology, College of Pharmacy, Jinan University, Guangzhou 510632, China. Electronic address: yanlijin2014@jnu.edu.cn. [9]State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China. Electronic address: panjx2@mail.sysu.edu.cn.
出处：
DOI： 10.1016/j.cmet.2022.04.004
ISSN：

摘要：
Our group has reported previously on the role of various members of the protein arginine methyltransferase (PRMT) family, which are involved in epigenetic regulation, in the progression of leukemia. Here, we explored the role of PRMT7, given its unique function within the PRMT family, in the maintenance of leukemia stem cells (LSCs) in chronic myeloid leukemia (CML). Genetic loss of Prmt7, and the development and testing of a small-molecule specific inhibitor of PRMT7, showed that targeting PRMT7 delayed leukemia development and impaired self-renewal of LSCs in a CML mouse model and in primary CML CD34+ cells from humans without affecting normal hematopoiesis. Mechanistically, loss of PRMT7 resulted in reduced expressions of glycine decarboxylase, leading to the reprograming of glycine metabolism to generate methylglyoxal, which is detrimental to LSCs. These findings link histone arginine methylation with glycine metabolism, while suggesting PRMT7 as a potential therapeutic target for the eradication of LSCs in CML.Copyright © 2022 Elsevier Inc. All rights reserved.

语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 1 区 生物学
小类 | 1 区 细胞生物学 1 区 内分泌学与代谢
最新[2023]版：
大类 | 1 区 生物学
小类 | 1 区 细胞生物学 1 区 内分泌学与代谢
JCR分区：
出版当年[2022]版：
Q1 CELL BIOLOGY Q1 ENDOCRINOLOGY & METABOLISM
最新[2023]版：
Q1 CELL BIOLOGY Q1 ENDOCRINOLOGY & METABOLISM

影响因子： 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者：
第一作者机构： [1]Jinan University Institute of Tumor Pharmacology, College of Pharmacy, Jinan University, Guangzhou 510632, China.
推荐引用方式(GB/T 7714)：
Liu Chang,Zou Waiyi,Nie Danian,et al.Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML.[J].CELL METABOLISM.2022,34(6):818-+.doi:10.1016/j.cmet.2022.04.004.
APA：
Liu Chang,Zou Waiyi,Nie Danian,Li Shuyi,Duan Chen...&Pan Jingxuan.(2022).Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML..CELL METABOLISM,34,(6)
MLA：
Liu Chang,et al."Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML.".CELL METABOLISM 34..6(2022):818-+

资源点击量：53080 今日访问量：0 总访问量：4588 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号